Increased ANGPT2 expression has also been described as a potential prognostic factor in colorectal carcinoma (13), gastric cancer (15), hepatocellular cancer (16, 17), lung cancer (18), and chronic lymphocytic leukemia (19). This evidence concerns the gene ANGPT2 and lung cancer.